Literature DB >> 16382280

Novel mucosal insulin delivery systems based on fusogenic liposomes.

Takahiro Goto1, Mariko Morishita, Ken Nishimura, Mahito Nakanishi, Atsushi Kato, Jumpei Ehara, Kozo Takayama.   

Abstract

PURPOSE: Fusogenic liposomes (FLs) are unique delivery vehicles capable of introducing their contents directly into the cytoplasm with the aid of envelope glycoproteins of Sendai virus (SeV). The objective of this study was to evaluate the potential of FL to improve the mucosal absorption of insulin from rat intestinal membranes.
METHOD: The FLs containing insulin were prepared by fusing insulin-loaded liposomes with inactivated SeV particles and were administered directly into the ileal, the colonic, and the rectal loops (10 IU/kg).
RESULTS: The FL successfully enhanced the insulin absorption and induced a significant hypoglycemic effect following the colonic and the rectal administration without detectable mucosal damage. This enhancing effect of insulin absorption was further improved by increasing the amount of insulin loaded in the FL and by coencapsulating insulin-degrading enzyme inhibitor. In contrast, the insulin absorption was not increased by the ileal administration of FL because the mucous/glycocalyx layers overlaid on the ileal epithelium impede the fusion of FL to the intestinal mucosa.
CONCLUSION: Our results indicated that FL is a useful carrier for improving the absorption of poorly absorbable drugs, such as insulin, via the intestinal tract.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16382280     DOI: 10.1007/s11095-005-9175-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  A novel vaccine delivery system using immunopotentiating fusogenic liposomes.

Authors:  A Hayashi; T Nakanishi; J Kunisawa; M Kondoh; S Imazu; Y Tsutsumi; K Tanaka; H Fujiwara; T Hamaoka; T Mayumi
Journal:  Biochem Biophys Res Commun       Date:  1999-08-11       Impact factor: 3.575

2.  Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat.

Authors:  M A Kisel; L N Kulik; I S Tsybovsky; A P Vlasov; M S Vorob'yov; E A Kholodova; Z V Zabarovskaya
Journal:  Int J Pharm       Date:  2001-03-23       Impact factor: 5.875

3.  Structural requirements for hemolytic activity of F-glycoprotein of HVJ (Sendai virus) studied by proteolytic dissection.

Authors:  K Asano; T Murachi; A Asano
Journal:  J Biochem       Date:  1983-03       Impact factor: 3.387

4.  Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats.

Authors:  C Q Xia; J Wang; W C Shen
Journal:  J Pharmacol Exp Ther       Date:  2000-11       Impact factor: 4.030

5.  The effect of oral absorption enhancers on the in vivo performance of insulin-loaded poly(ethylcyanoacrylate) nanospheres in diabetic rats.

Authors:  M A Radwant; H Y Aboul-Enein
Journal:  J Microencapsul       Date:  2002 Mar-Apr       Impact factor: 3.142

6.  Effects of enzyme inhibitors and insulin concentration on transepithelial transport of insulin in rats.

Authors:  J P Bai; L L Chang
Journal:  J Pharm Pharmacol       Date:  1996-10       Impact factor: 3.765

7.  Expression of hepatitis B virus surface antigen in adult rat liver. Co-introduction of DNA and nuclear protein by a simplified liposome method.

Authors:  K Kato; M Nakanishi; Y Kaneda; T Uchida; Y Okada
Journal:  J Biol Chem       Date:  1991-02-25       Impact factor: 5.157

8.  In situ ileal absorption of insulin in rats: effects of hyaluronidase pretreatment diminishing the mucous/glycocalyx layers.

Authors:  Mariko Morishita; Yoshinobu Aoki; Masahiro Sakagami; Tsuneji Nagai; Kozo Takayama
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

9.  Transepithelial transport of insulin: I. Insulin degradation by insulin-degrading enzyme in small intestinal epithelium.

Authors:  J P Bai; L L Chang
Journal:  Pharm Res       Date:  1995-08       Impact factor: 4.200

10.  Apical barriers to airway epithelial cell gene transfer with amphotropic retroviral vectors.

Authors:  G Wang; G Williams; H Xia; M Hickey; J Shao; B L Davidson; P B McCray
Journal:  Gene Ther       Date:  2002-07       Impact factor: 5.250

View more
  4 in total

1.  Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study.

Authors:  Alyaa Ramadan; Frederic Lagarce; Anne Tessier-Marteau; Olivier Thomas; Pierre Legras; Laurent Macchi; Patrick Saulnier; Jean Pierre Benoit
Journal:  Int J Nanomedicine       Date:  2011-11-21

Review 2.  Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine.

Authors:  Mahito Nakanishi; Makoto Otsu
Journal:  Curr Gene Ther       Date:  2012-10       Impact factor: 4.391

Review 3.  Lipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles.

Authors:  Susana Martins; Bruno Sarmento; Domingos C Ferreira; Eliana B Souto
Journal:  Int J Nanomedicine       Date:  2007

Review 4.  Photosensitive drugs: a review on their photoprotection by liposomes and cyclodextrins.

Authors:  Giuseppina Ioele; Michele De Luca; Antonio Garofalo; Gaetano Ragno
Journal:  Drug Deliv       Date:  2017-12       Impact factor: 6.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.